Cargando…

New Acetylcholinesterase Inhibitors for Alzheimer's Disease

Acetylcholinesterase (AChE) remains a highly viable target for the symptomatic improvement in Alzheimer's disease (AD) because cholinergic deficit is a consistent and early finding in AD. The treatment approach of inhibiting peripheral AchE for myasthenia gravis had effectively proven that AchE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehta, Mona, Adem, Abdu, Sabbagh, Marwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246720/ https://www.ncbi.nlm.nih.gov/pubmed/22216416 http://dx.doi.org/10.1155/2012/728983

Ejemplares similares

Novel Therapeutics in Alzheimer's Disease
por: Sabbagh, Marwan, et al.
Publicado: (2012)

Is diabetes associated with increased pathological burden in Alzheimer's disease?
por: Sadrolashrafi, Kaviyon, et al.
Publicado: (2021)

Discovery of new acetylcholinesterase inhibitors for Alzheimer’s disease: virtual screening and in vitro characterisation
por: David, Benoit, et al.
Publicado: (2021)

Molecular docking analysis of acetylcholinesterase inhibitors for Alzheimer's disease management
por: Hakeem, Israa J
Publicado: (2023)

Language impairment in Alzheimer’s disease and benefits of acetylcholinesterase inhibitors
por: Ferris, Steven H, et al.
Publicado: (2013)

The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
por: Vecchio, Immacolata, et al.
Publicado: (2021)

Efficacy of Souvenaid(®) Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer’s Disease
por: García-Alberca, José María, et al.
Publicado: (2023)

FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer’s disease
por: Paroni, Giulia, et al.
Publicado: (2014)

Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer’s Disease
por: Son, Minky, et al.
Publicado: (2019)

Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy
por: dos Santos, Thaiane Coelho, et al.
Publicado: (2018)

Efficacy of Acetylcholinesterase Inhibitors on Cognitive Function in Alzheimer’s Disease. Review of Reviews
por: Moreta, Marta Pérez-Gómez, et al.
Publicado: (2021)

N-Acetylcholinesterase-Induced Apoptosis in Alzheimer's Disease
por: Toiber, Debra, et al.
Publicado: (2008)

Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer’s Disease: Are Irreversible Inhibitors the Future?
por: Moss, Donald E.
Publicado: (2020)

Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease
por: Semenov, Vyacheslav E., et al.
Publicado: (2020)

Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis
por: Walczak-Nowicka, Łucja Justyna, et al.
Publicado: (2021)

Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer’s Disease: A Narrative Review
por: Young, Sara, et al.
Publicado: (2021)

Acetylcholinesterase inhibitor modifications: a promising strategy to delay the progression of Alzheimer's disease
por: Bhattacharya, Soumee, et al.
Publicado: (2015)

Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer′s Disease Therapy
por: Boulebd, Houssem, et al.
Publicado: (2016)

Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer’s Diseases
por: Guo, Yan, et al.
Publicado: (2020)

A Novel Application of Multiscale Entropy in Electroencephalography to Predict the Efficacy of Acetylcholinesterase Inhibitor in Alzheimer's Disease
por: Tsai, Ping-Huang, et al.
Publicado: (2015)

Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease
por: Devita, Maria, et al.
Publicado: (2021)

Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease
por: Zou, Dajiang, et al.
Publicado: (2023)

Altered Levels of Acetylcholinesterase in Alzheimer Plasma
por: García-Ayllón, María-Salud, et al.
Publicado: (2010)

Acetylcholinesterase inhibitors attenuate angiogenesis
por: Miyazaki, Ryohei, et al.
Publicado: (2012)

Heterologous Amyloid Seeding: Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease
por: Jean, Létitia, et al.
Publicado: (2007)

Novel harmine derivatives as potent acetylcholinesterase and amyloid beta aggregation dual inhibitors for management of Alzheimer’s disease
por: Du, Hongtao, et al.
Publicado: (2023)

Development of p-Tau Differentiated Cell Model of Alzheimer’s Disease to Screen Novel Acetylcholinesterase Inhibitors
por: Uras, Giuseppe, et al.
Publicado: (2022)

Synthesis of New Indole Derivatives Structurally Related to Donepezil and Their Biological Evaluation as Acetylcholinesterase Inhibitors
por: Ismail, Mohamed M., et al.
Publicado: (2012)

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation
por: El-Hussieny, Marwa, et al.
Publicado: (2023)

Synthesis and Biological Evaluation of Thiophene Derivatives as Acetylcholinesterase Inhibitors
por: Ismail, Mohamed M., et al.
Publicado: (2012)

White matter hyperintensities in cholinergic pathways may predict poorer responsiveness to acetylcholinesterase inhibitor treatment for Alzheimer’s disease
por: Lee, Li-Hua, et al.
Publicado: (2023)

Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
por: Čolović, Mirjana B, et al.
Publicado: (2013)

Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer’s Disease
por: Semenov, Vyacheslav E., et al.
Publicado: (2022)

Molecular interaction of human acetylcholinesterase with trans-tephrostachin and derivatives for Alzheimer's disease
por: Pitchai, Arjun, et al.
Publicado: (2020)

Proposing novel natural compounds against Alzheimer’s disease targeting acetylcholinesterase
por: Girgin, Münteha, et al.
Publicado: (2023)

Alzheimer's disease drug development pipeline: 2020
por: Cummings, Jeffrey, et al.
Publicado: (2020)

Broader Considerations of Higher Doses of Donepezil in the Treatment of Mild, Moderate, and Severe Alzheimer's Disease
por: Berk, Camryn, et al.
Publicado: (2012)

Corpus callosum anatomical changes in Alzheimer patients and the effect of acetylcholinesterase inhibitors on corpus callosum morphometry
por: Khasawneh, Ramada R., et al.
Publicado: (2022)

Editorial Introduction to the Special Issue from the International Symposium on Biomarkers for Alzheimer’s Disease and Related Disorders
por: Sabbagh, Marwan N.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ptsqlhkeageu4qbp8isam4876s